Pharmaceuticals news continually updated from thousands of sources around the net.
1 hr ago | Customer Interaction Solutions
Fitch Ratings has downgraded the ratings of Teva Pharmaceutical Industries Limited to 'BBB+' from 'A-'.
Should states get to ban abortion?
Should states lower the drinking age to 18?
5 hrs ago | Insider Monkey
Peter Kolchinsky and Ra Capital Management are betting big on Xencor Inc . In a recent filing with the Securities and Exchange Commission, Ra Capital has revealed opening a new position by acquiring 2.7 million shares of Xencor.
9 hrs ago | MarketNewsVideo
This morning, UBS increased its price target on shares of CVS Caremark to $77 after the joint venture with Cardinal Health was announced.
13 hrs ago | Global Logistics/Supply Chain
Yusen Logistics has joined with Imperial Health Sciences to provide a temperature-controlled sea-freight consolidation service to Southern Africa for the pharmaceutical industry.
Good morning, everyone, and welcome to Cardinal Health investor and analyst event.
Bristol-Myers Squibb Company today announced that its Board of Directors has elected Thomas J. Lynch, Jr., M.D. to the Board, effective January 1, 2014.
Evidence is building that bacteria in our bodies can provide some vitamins that we need.
Pharmacy chain CVS Caremark Corp and pharmaceutical distributor Cardinal Health Inc on Tuesday announced a 10-year agreement to form the largest generic drug sourcing operation in the United States, the world's biggest generic drug market.
Hedge Fund Elliott Proposes Celesio Breakup Hedge fund Elliott Capital Advisors considers drug wholesaler McKesson Corporation -0.33% $6.1 billion takeover offer for Germany's Celesio AG CLS1.XE +0.35% too low, and is instead proposing to break up Celesio in pursuit of a sweeter deal, three people familiar with the matter said.
Federal regulators expressed concern that a new diabetes drug being developed by Bristol-Myers Squibb and AstraZeneca may have risks that outweigh its benefits.
Teva Pharmaceutical Industries , the world's biggest generic drugmaker, forecast a big drop in profit in 2014 if cheap generic competition to its blockbuster multiple sclerosis treatment Copaxone is launched.
The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in October 2013.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that a joint panel of members from the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committees of the United States Food and Drug Administration voted to recommend approval of Takeda's vedolizumab for ... (more)
NEW ORLEANS & OSAKA, Japan -- -- Takeda Pharmaceutical Company Limited today announced final Phase 1 and preliminary Phase 2 results of a study combining oral investigational MLN9708 administered twice a week with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma .
Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited today announced updated overall survival data from two ADCETRIS pivotal Phase 2 clinical trials in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large cell lymphoma were presented at the 55th American Society of Hematology Annual Meeting and ... (more)